Valeant takes offer to Allergan shareholders

18 June 2014 - Deborah Wilkes


Canada's Valeant Pharmaceuticals International has taken its unsolicited takeover offer for Allergan directly to shareholders, after the board of the Botox maker rejected the proposal valuing the company at around US$53 billion.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: